Alavi AM., Dubyak GR., Burnstock G. Immunohistochemical evidence for ATP receptors in human dental pulp. J Dent Res. 80:476–483. 2001.
Article
Bleehen T., Keele CA. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain. 3:367–377. 1977.
Article
Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet. 347:1604–1605. 1996.
Article
Burnstock G., Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol. 6:526–532. 1996.
Article
Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 110:433–454. 2006.
Article
Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 64:1471–1483. 2007.
Article
Caterina MJ., Leffler A., Malmberg AB., Martin WJ., Trafton J., Petersen-Zeitz KR., Koltzenburg M., Basbaum AI., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:306–313. 2000.
Article
Chen CC., Akopian AN., Sivilotti L., Colquhoun D., Burnstock G., Wood JN. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:428–431. 1995.
Article
Chung G., Rhee JN., Jung SJ., Kim JS., Oh SB. Modulation of CaV2.3 calcium channel currents by eugenol. J Dent Res. 87:137–141. 2008.
Article
Cook SP., McCleskey EW. Desensitization, recovery and Ca(2+)-dependent modulation of ATP-gated P2X receptors in nociceptors. Neuropharmacology. 36:1303–1308. 1997.
Article
Cook SP., Vulchanova L., Hargreaves KM., Elde R., McCleskey EW. Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature. 387:505–508. 1997.
Article
Cook SP., McCleskey EW. Cell damage excites nociceptors through release of cytosolic ATP. Pain. 95:41–47. 2002.
Article
Craig RG., Powers JM. Biocompatibility of dental materials. Restorative dental materials. St. Louis: Mosby;p. p. 154–155. 2002.
Dunn PM., Zhong Y., Burnstock G. P2X receptors in peripheral neurons. Prog Neurobiol. 65:107–134. 2001.
Article
Eriksson J., Bongenhielm U., Kidd E., Matthews B., Fried K. Distribution of P2×3 receptors in the rat trigeminal ganglion after inferior alveolar nerve injury. Neurosci Lett. 254:37–40. 1998.
Gerevich Z., Zadori Z., Müller C., Wirkner K., Schröder W., Rubini P., Illes P. Metabotropic P2Y receptors inhibit P2×3 receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol. 151:226–236. 2007.
Guo A., Vulchanova L., Wang J., Li X., Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2×3 purinoceptor and IB4 binding sites. Eur J Neurosci. 11:946–958. 1999.
Ichikawa H., Sugimoto T. The co-expression of P2×3 receptor with VR1 and VRL-1 in the rat trigeminal ganglia. Brain Res. 998:130–135. 2004.
Jiang J., Gu J. Expression of adenosine triphosphate P2×3 receptors in rat molar pulp and trigeminal ganglia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 94:622–626. 2002.
Kollarik M., Dinh QT., Fischer A., Undem BJ. Capsaicin-sensitive and -insensitive vagal bronchopulmonary C-fibres in the mouse. J Physiol. 551:869–879. 2003.
Article
Lee MH., Yeon KY., Park CK., Li HY., Fang Z., Kim MS., Choi SY., Lee SJ., Lee S., Park K., Lee JH., Kim JS., Oh SB. Eugenol inhibits calcium currents in dental afferent neurons. J Dent Res. 84:848–851. 2005.
Article
Lewis C., Neidhart S., Holy C., North RA., Buell G., Surprenant A. Coexpression of P2×2 and P2×3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 377:432–435. 1995.
Li HY., Oh SB., Kim JS. Pharmacological and electrophysiological characterization of rat P2X currents. IJOB. 33:1–5. 2008.
Li HY., Park CK., Jung SJ., Choi SY., Lee SJ., Park K., Kim JS., Oh SB. Eugenol inhibits K+ currents in trigeminal ganglion neurons. J Dent Res. 86:898–902. 2007.
Article
Luo J., Yin GF., Gu YZ., Liu Y., Dai JP., Li C., Li ZW. Characterization of three types of ATP-activated current in relation to P2X subunits in rat trigeminal ganglion neurons. Brain Res. 1115:9–15. 2006.
Article
North RA. Molecular physiology of P2X receptors. Physiol Rev. 82:1013–1067. 2002.
Article
North RA. The P2×3 subunit: a molecular target in pain therapeutics. Curr Opin Investig Drugs. 4:833–840. 2003.
North RA. P2×3 receptors and peripheral pain mechanisms. J Physiol. 554:301–308. 2004.
Park CK., Li HY., Yeon KY., Jung SJ., Choi SY., Lee SJ., Lee S., Park K., Kim JS., Oh SB. Eugenol inhibits sodium currents in dental afferent neurons. J Dent Res. 85:900–904. 2006.
Article
Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 50:413–492. 1998.
Renton T., Yiangou Y., Baecker PA., Ford AP., Anand P. Capsaicin receptor VR1 and ATP purinoceptor P2×3 in painful and nonpainful human tooth pulp. J Orofac Pain. 17:245–250. 2003.
Sarrami N., Pemberton MN., Thornhill MH., Theaker ED. Adverse reactions associated with the use of eugenol in dentistry. Br Dent J. 193:257–259. 2002.
Article
Tsuda M., Ueno S., Inoue K. In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br J Pharmacol. 127:449–456. 1999.
Xiang Z., Bo X., Burnstock G. Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neurosci Lett. 256:105–108. 1998.
Article
Yang BH., Piao ZG., Kim YB., Lee CH., Lee JK., Park K., Kim JS., Oh SB. Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res. 82:781–785. 2003.
Article